3
H index
1
i10 index
38
Citations
Moritz Suppliet : Citation Profile
Universiteit van Tilburg (20% share) | RESEARCH PRODUCTION: 4 Articles 15 Papers RESEARCH ACTIVITY:
MORE DETAILS IN: ABOUT THIS REPORT:
|
9 years (2011 - 2020). Relations with other researchers
Works with: Authors registered in RePEc who have co-authored more than one work in the last five years with Moritz Suppliet. | Is cited by:
| Cites to:
|
Main data
Where Moritz Suppliet has published?
| Journals with more than one article published | # docs |
|---|---|
| Journal of Health Economics | 2 |
| Working Papers Series with more than one paper published | # docs |
|---|---|
| DICE Discussion Papers / Heinrich Heine University D�sseldorf, D�sseldorf Institute for Competition Economics (DICE) | 2 |
Recent works citing Moritz Suppliet (2025 and 2024)
Year  | Title of citing document |
|---|---|
| 2024 | Opium Price Shocks and Prescription Opioids in the USA*. (2024). Nisticò, Roberto ; Giua, Ludovica ; Deiana, Claudio. In: Oxford Bulletin of Economics and Statistics. RePEc:bla:obuest:v:86:y:2024:i:3:p:449-484. Full description at Econpapers || Download paper |
| 2024 | Antibacterial resistance and the cost of affecting demand: The case of UK antibiotics. (2024). Bokhari, Farasat ; Yan, Weijie ; Mariuzzo, Franco. In: International Journal of Industrial Organization. RePEc:eee:indorg:v:95:y:2024:i:c:s0167718724000377. Full description at Econpapers || Download paper |
| 2024 | Passthrough of Retail Price Regulation in the Market for Pharmaceuticals. (2024). Markkanen, Jaakko. In: ETLA Working Papers. RePEc:rif:wpaper:123. Full description at Econpapers || Download paper |
Works by Moritz Suppliet:
| Year | Title | Type | Cited |
|---|---|---|---|
| 2015 | Vergleichbarkeit internationaler Arzneimittelpreise: Internationale Preisreferenzierung in Deutschland durch das AMNOG In: Perspektiven der Wirtschaftspolitik. [Full Text][Citation analysis] | article | 1 |
| 2014 | Vergleichbarkeit internationaler Arzneimittelpreise: Internationale Preisreferenzierung in Deutschland durch das AMNOG.(2014) In: DICE Ordnungspolitische Perspektiven. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 1 | paper | |
| 2014 | The Welfare Impact of Parallel Imports: A Structural Approach Applied to the German Market for Oral Anti-Diabetics In: Discussion Papers of DIW Berlin. [Full Text][Citation analysis] | paper | 24 |
| 2014 | THE WELFARE IMPACT OF PARALLEL IMPORTS: A STRUCTURAL APPROACH APPLIED TO THE GERMAN MARKET FOR ORAL ANTI‐DIABETICS.(2014) In: Health Economics. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 24 | article | |
| 2014 | The Welfare Impact of Parallel Imports: A Structural Approach Applied to the German Market for Oral Anti-diabetics.(2014) In: Health, Econometrics and Data Group (HEDG) Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 24 | paper | |
| 2014 | The welfare impact of parallel imports: A structural approach applied to the German market for oral anti-diabetics.(2014) In: DICE Discussion Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 24 | paper | |
| 2014 | The welfare impact of parallel imports: A structural approach applied to the German market for oral antidiabetics.(2014) In: VfS Annual Conference 2014 (Hamburg): Evidence-based Economic Policy. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 24 | paper | |
| 2017 | Tiered co-payments, pricing, and demand in reference price markets for pharmaceuticals In: Journal of Health Economics. [Full Text][Citation analysis] | article | 3 |
| 2020 | Umbrella branding in pharmaceutical markets In: Journal of Health Economics. [Full Text][Citation analysis] | article | 4 |
| 2017 | Umbrella Branding in Pharmaceutical Markets.(2017) In: Discussion Paper. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 4 | paper | |
| 2017 | Umbrella Branding in Pharmaceutical Markets.(2017) In: Discussion Paper. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 4 | paper | |
| 2016 | Cost-Sharing and Drug Pricing Strategies : Introducing Tiered Co-Payments in Reference Price Markets In: Discussion Paper. [Full Text][Citation analysis] | paper | 6 |
| 2016 | Cost-Sharing and Drug Pricing Strategies : Introducing Tiered Co-Payments in Reference Price Markets.(2016) In: Discussion Paper. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 6 | paper | |
| 2011 | Co-Payment Exemptions and Reference Prices: an Empirical Study of Pharmaceutical Prices in Germany.(2011) In: Health, Econometrics and Data Group (HEDG) Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 6 | paper | |
| 2012 | Pharmaceutical prices under regulation: Tiered co-payments and reference pricing in Germany.(2012) In: DICE Discussion Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 6 | paper | |
| 2016 | Cost-Sharing and Drug Pricing Strategies : Introducing Tiered Co-Payments in Reference Price Markets In: Other publications TiSEM. [Full Text][Citation analysis] | paper | 0 |
| 2016 | Cost-Sharing and Drug Pricing Strategies : Introducing Tiered Co-Payments in Reference Price Markets In: Other publications TiSEM. [Full Text][Citation analysis] | paper | 0 |
| 2017 | Umbrella Branding in Pharmaceutical Markets In: Other publications TiSEM. [Full Text][Citation analysis] | paper | 0 |
| 2017 | Umbrella Branding in Pharmaceutical Markets In: Other publications TiSEM. [Full Text][Citation analysis] | paper | 0 |
CitEc is a RePEc service, providing citation data for Economics since 2001. Last updated February, 4 2025. Contact: CitEc Team